Pancreatic cancer has relatively few coding mutations and thus only few neo-antigenic targets, and is embedded in an immunosuppressive cold tumor microenvironment, which impedes intratumoral CD8+ T cell infiltration and activation (Bear et al., 2020). The gene discussed is CD8A; the disease is familial pancreatic carcinoma.